Non Alcoholic Fatty Liver Disease Stocks List

Symbol	Grade	Name	% Change
VKTX	F	Viking Therapeutics, Inc.	0.19
TERN	F	Terns Pharmaceuticals, Inc.	1.96
BFRG	F	Bullfrog AI Holdings, Inc	-0.50
GLTO	F	Galecto, Inc.	0.60

Symbol	Grade	Name	Weight
OZEM	F	Roundhill GLP-1 & Weight Loss ETF	5.36
ADPV	A	Adaptiv Select ETF	2.72
THNR	F	Amplify Weight Loss Drug & Treatment ETF	2.72
BBC	D	Virtus LifeSci Biotech Clinical Trials ETF	2.4
XBI	D	SPDR S&P Biotech ETF	2.0

Compare ETFs

Compare ADPV to BBC Compare OZEM to THNR Compare THNR to BBC

Date	Stock	Title
Nov 20	VKTX	Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
Nov 19	VKTX	Viking phase 2b study of NASH candidate hits primary endpoint
Nov 19	VKTX	Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
Nov 19	TERN	Top 3 Health Care Stocks You'll Regret Missing In Q4
Nov 18	TERN	Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
Nov 18	VKTX	3 Things You Need to Know if You Buy Viking Therapeutics Today
Nov 17	VKTX	Is It Too Late to Buy Viking Therapeutics Stock?
Nov 16	VKTX	Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
Nov 15	VKTX	Market Whales and Their Recent Bets on VKTX Options
Nov 15	VKTX	Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

Non Alcoholic Fatty Liver Disease: Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver, causing inflammation and damage. It is the most common form of liver disease in the United States, affecting up to 25% of the population. NAFLD is closely linked to obesity, diabetes, and high cholesterol, and can lead to serious complications such as cirrhosis and liver cancer. Treatment typically involves lifestyle changes such as weight loss, exercise, and a healthy diet.